The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
At least 10 people have been injured after more than 50 cars were involved in a pile-up on a busy highway in Pennsylvania.
A teenager who grew an incredible 10cm overnight after an operation to correct a curve in her spine has been given the all clear by doctors.
Severe weather warnings have been issued for northern England and Scotland, where it could drop to minus 10C (14F) in some places.